Related Experiment Video

Updated: Aug 6, 2026

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
09:09

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients

Published on: April 3, 2026

Personalized genomic medicine: a future prerequisite for the prevention of coronary artery disease

Robert Roberts1, Alexandre Fr Stewart

  • 1Division of Cardiology, Univeristy of Ottawa Heart Institute, Ottawa, Ontario, Canada. rroberts@ottawaheart.ca

The American Heart Hospital Journal
|August 9, 2006
PubMed

Insights

Personalized medicine will use genomic variants to prevent coronary artery disease (CAD), the leading cause of death. Genome-wide scanning and advanced imaging will identify genetic susceptibility for comprehensive CAD prevention.

Area of Science:

  • Genetics
  • Cardiovascular Disease
  • Personalized Medicine

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality globally.
  • Approximately 50% of CAD susceptibility is attributed to genetic factors.
  • Current prevention strategies focus on risk factors, but genetic predisposition requires further investigation.

Purpose of the Study:

  • To explore the role of genomic variants in coronary artery disease susceptibility.
  • To investigate the potential of genome-wide scanning for identifying CAD-related genes.
  • To assess the utility of multislice CT for coronary arteriography in prevention research.

Main Methods:

  • Utilizing a DNA chip with 500,000 markers for genome-wide scanning.
  • Employing multislice CT for high-throughput coronary arteriograms.
  • Integrating genomic data with imaging for comprehensive risk assessment.

Main Results:

  • Genome-wide scanning enables identification of genes contributing to CAD.
  • Multislice CT provides necessary imaging for research and prevention in at-risk individuals.
  • Personalized medicine approaches incorporating genetic data are emerging.

Conclusions:

  • Genomic variants play a significant role in coronary artery disease susceptibility.
  • Advanced technologies like genome-wide scanning and multislice CT are crucial for personalized prevention.
  • Integrating genetic information into healthcare will be key to eliminating CAD in the 21st century.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...